Abstract
The impact of leprosy and HIV co-infection is an evolving picture. Surprisingly the outcomes that were feared, of more lepromatous disease has not materialised. But with the roll-out of antiretroviral therapy, the emergence of leprosy as Immune Reconstitution Inflammatory Syndrome is re-focusing attention on the characteristics of this important co-infection.
MeSH terms
-
AIDS-Related Opportunistic Infections / diagnosis
-
AIDS-Related Opportunistic Infections / drug therapy
-
AIDS-Related Opportunistic Infections / immunology
-
Adult
-
Anti-Retroviral Agents / administration & dosage
-
CD4 Lymphocyte Count
-
Comorbidity
-
Female
-
HIV Infections / complications*
-
HIV Infections / drug therapy
-
HIV Infections / immunology
-
HIV Infections / physiopathology
-
Humans
-
Immune Reconstitution Inflammatory Syndrome / chemically induced*
-
Immunity, Cellular
-
Leprostatic Agents / administration & dosage
-
Leprosy / complications*
-
Leprosy / immunology
-
Leprosy / physiopathology
-
Male
-
Mycobacterium leprae / immunology
-
Mycobacterium leprae / isolation & purification
Substances
-
Anti-Retroviral Agents
-
Leprostatic Agents